Inhibition of lupus by genetic alteration of the interferon-alpha/beta receptor (Q35675526)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on December 2003

Language	Label	Description	Also known as
English	Inhibition of lupus by genetic alteration of the interferon-alpha/beta receptor	scientific article published on December 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1 reference

Europe PubMed Central

Inhibition of lupus by genetic alteration of the interferon-alpha/beta receptor (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

author name string

Dwight H Kono

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Roberto Baccala

2

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Argyrios N Theofilopoulos

3

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

publication date

1 December 2003

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

36

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

503-510

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Immune Interferon in the Circulation of Patients with Autoimmune Disease

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE).

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Hyperinducible expression of the interferon-gamma (IFN-gamma) gene and its suppression in systemic lupus erythematosus (SLE).

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Immune-mediated complications during interferon therapy in hematological patients

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Increased activation and altered ratio of interferon-gamma: interleukin-4 secreting cells in MRL-lpr/lpr mice.

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Cytokine mRNA expression in the B/W mouse model of systemic lupus erythematosus--analyses of strain, gender, and age effects.

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice.

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Promotion of lupus in NZB x NZWF1 mice by plasmids encoding interferon (IFN)-gamma but not by those encoding interleukin (IL)-4.

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Reduction of serum interferon (IFN)-gamma concentration and lupus development in NZBxNZWF(1)mice by lactic dehydrogenase virus infection

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Roles of interferon-gamma and interleukin-4 in murine lupus

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

T-bet regulates IgG class switching and pathogenic autoantibody production

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Autoimmune disease complicating antiviral therapy for hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

An etiopathogenic role for the type I IFN system in SLE.

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

The natural interferon-alpha producing cells in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Involvement of plasmacytoid dendritic cells in human diseases.

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Plasmacytoid dendritic cells: from specific surface markers to specific cellular functions

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

The interplay of dendritic cell subsets in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Anti-interferon globulin inhibits the development of glomerulonephritis in mice infected at birth with lymphocytic choriomeningitis virus

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Genetics of systemic autoimmunity in mouse models of lupus

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

IL-28, IL-29 and their class II cytokine receptor IL-28R

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Novel interferons

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

The family of IL-10-related cytokines and their receptors: related, but to what extent?

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Activation and differentiation of autoreactive B-1 cells by interleukin 10 induce autoimmune hemolytic anemia in Fas-deficient antierythrocyte immunoglobulin transgenic mice

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Interferons alpha and beta as immune regulators--a new look

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

A weak signal for strong responses: interferon-alpha/beta revisited

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Impairment of T and B cell development by treatment with a type I interferon

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

IFNalpha/beta promotes cell survival by activating NF-kappa B

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Autoantibody production and cytokine profiles of MHC class I (beta2-microglobulin) gene deleted New Zealand black (NZB) mice

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

The interferon regulatory transcription factor IRF-1 controls positive and negative selection of CD8+ thymocytes.

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking interferon regulatory factor-1.

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Type I interferons keep activated T cells alive

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Induction of bystander T cell proliferation by viruses and type I interferon in vivo

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15.

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

IRF family of transcription factors as regulators of host defense

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Delineating the genetic basis of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Interferon-inducible p202 in the susceptibility to systemic lupus

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Interleukin-10 modulates the sensitivity of peritoneal B lymphocytes to chemokines with opposite effects on stromal cell-derived factor-1 and B-lymphocyte chemoattractant

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE)--relation to Th1- and Th2-derived cytokines

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Increased interferon-gamma (IFN-gamma), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE)

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Serum interferon levels in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Up-regulated MHC-class II expression and gamma-IFN and soluble IL-2R in lupus nephritis

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Association of the interferon-gamma receptor variant (Val14Met) with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

The combination of polymorphisms within interferon-gamma receptor 1 and receptor 2 associated with the risk of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1 beta, interleukin-1 and interferon-gamma mRNA in the lymph nodes of lupus-prone mice

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Upregulation of lymphoid and renal interferon-gamma mRNA in autoimmune MRL-Fas(lpr) mice with lupus nephritis

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Interferon-gamma is required for lupus nephritis in mice treated with the hydrocarbon oil pristane

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Importance of CpG dinucleotides in activation of natural IFN-alpha-producing cells by a lupus-related oligodeoxynucleotide

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Activation of natural interferon-alpha producing cells by apoptotic U937 cells combined with lupus IgG and its regulation by cytokines

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Blood dendritic cells and DC-poietins in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Type I Interferon controls the onset and severity of autoimmune manifestations in lpr mice

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Administration of interleukin-5 or -10 activates peritoneal B-1 cells and induces autoimmune hemolytic anemia in anti-erythrocyte autoantibody-transgenic mice

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Interferon-beta increases the stimulatory capacity of monocyte-derived dendritic cells to induce IL-13, IL-5 and IL-10 in autologous T-cells

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Interferon-? therapy for multiple sclerosis induces reciprocal changes in interleukin-12 and interleukin-10 production

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

IFN-alpha/beta enhances BCR-dependent B cell responses

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Complete suppression of insulitis and diabetes in NOD mice lacking interferon regulatory factor-1

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Requirement of the IFN-alpha/beta-induced CXCR3 chemokine signalling for CD8+ T cell activation

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Genetic susceptibility to systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Type I interferons produced by dendritic cells promote their phenotypic and functional activation

1 reference

https://api.crossref.org/works/10.1080%2F08916930310001624665

21 January 2018

Identifiers

10.1080/08916930310001624665

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35675526&oldid=2049228816"